# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001757064-22-000003
Filing Date
2022-04-29
Accepted
2022-04-29 10:34:54
Documents
149
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | gnft-20211231.htm iXBRL | 20-F | 6691565
2 | EX-1.2 ARTICLES OF ASSOCIATION | genfit-ex12articlesofassoc.htm | EX-1.2 | 134854
3 | EX-2.4 SHARE DESCRIPTION | genfit-ex24sharedescription.htm | EX-2.4 | 243742
4 | EX-4.5 SUMMARY 2021 FREE SHARE PLAN | genfit-ex45summaryoffreesh.htm | EX-4.5 | 13228
5 | EX-4.9 SUMMARY 2021 STOCK OPTION PLAN | genfit-ex49summaryofstocko.htm | EX-4.9 | 26294
6 | EX-4.12 AGREEMENT WITH IPSEN PHARMA SAS | genfit-ex412agreementwithi.htm | EX-4.12 | 657602
7 | EX-12.1 | genfit-exhibit121.htm | EX-12.1 | 11696
8 | EX-12.2 | genfit-exhibit122.htm | EX-12.2 | 11501
9 | EX-13.1 | genfit-exhibit131.htm | EX-13.1 | 6367
10 | EX-13.2 | genfit-exhibit132.htm | EX-13.2 | 6426
16 |  | gnft-20211231_g1.jpg | GRAPHIC | 557631
17 |  | gnft-20211231_g10.jpg | GRAPHIC | 1168062
18 |  | gnft-20211231_g11.jpg | GRAPHIC | 1325490
19 |  | gnft-20211231_g12.jpg | GRAPHIC | 131456
20 |  | gnft-20211231_g2.jpg | GRAPHIC | 106989
21 |  | gnft-20211231_g3.jpg | GRAPHIC | 708400
22 |  | gnft-20211231_g4.jpg | GRAPHIC | 209491
23 |  | gnft-20211231_g5.jpg | GRAPHIC | 101981
24 |  | gnft-20211231_g6.jpg | GRAPHIC | 103900
25 |  | gnft-20211231_g7.jpg | GRAPHIC | 84874
26 |  | gnft-20211231_g8.jpg | GRAPHIC | 515684
27 |  | gnft-20211231_g9.jpg | GRAPHIC | 566730
28 |  | image_0c.jpg | GRAPHIC | 457
| Complete submission text file | 0001757064-22-000003.txt |  | 41330820

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | gnft-20211231.xsd | EX-101.SCH | 163620
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | gnft-20211231_cal.xml | EX-101.CAL | 117333
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | gnft-20211231_def.xml | EX-101.DEF | 672459
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | gnft-20211231_lab.xml | EX-101.LAB | 1329161
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | gnft-20211231_pre.xml | EX-101.PRE | 934788
143 | EXTRACTED XBRL INSTANCE DOCUMENT | gnft-20211231_htm.xml | XML | 6641552

Mailing Address PARC EURASANTE 885, AVENUE EUGENE AVINEE LOOS I0 59120
Business Address PARC EURASANTE 885, AVENUE EUGENE AVINEE LOOS I0 59120 33 3 20 16 4000
Genfit S.A. (Filer) CIK: 0001757064 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38844 | Film No.: 22871374
SIC: 2836 Biological Products, (No Diagnostic Substances)